文献速递瘢痕与激光创面修复美容整形

组织基质血管组分改善早期瘢痕愈合:一项前瞻性随机多中心临床试验

Tissue Stromal Vascular Fraction Improves Early Scar Healing: A Prospective Randomized Multicenter Clinical Trial.
PubMed 文献 · Aesthet Surg J · 2022-01-01

该前瞻性、双盲、安慰剂对照、随机试验于2016至2020年纳入40例乳房成形术患者,术中在一侧乳房水平瘢痕外侧5 cm注射组织基质血管组分(tSVF),对侧注射安慰剂作为患者内对照,随访1年。34例完成随访,术后6个月tSVF注射显著改善POSAS评估的瘢痕外观,但术后12个月无差异;照片评估和组织学分析均未见组间改善。

要点

  • 术后6个月tSVF注射显著改善POSAS问卷评估的瘢痕外观。
  • 术后12个月POSAS评估未见差异。
  • 照片评估和组织学分析均未见组间改善。

核心结论

  • tSVF注射在术后6个月改善创面愈合、减少瘢痕形成,但术后12个月未见明显有益效果。

研究设计与样本

  • 前瞻性、双盲、安慰剂对照、随机试验,于2016至2020年开展,纳入40例乳房成形术患者并随访1年。

主要发现

  • 40例患者中34例完成随访。
  • 术后6个月,tSVF注射显著改善POSAS问卷评估的术后瘢痕外观。
  • 术后12个月,POSAS评估未见差异。
  • 照片评估和组织学分析显示两组术后瘢痕之间均未见改善。

关键数值与推荐

  • 主要结局为患者与观察者瘢痕评估量表(POSAS)测量的瘢痕质量。
  • 次要结局来自照片评估和瘢痕组织样本的组织学分析。
  • 所有患者在一侧乳房水平瘢痕外侧5 cm接受tSVF注射,对侧注射安慰剂作为患者内对照。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Wound healing and scar formation depends on a plethora of factors. Given the impact of abnormal scar formation, interventions aimed to improve scar formation would be most advantageous. The tissue stromal vascular fraction (tSVF) of adipose tissue is composed of a heterogenous mixture of cells embedded in extracellular matrix. It contains growth factors and cytokines involved in wound-healing processes, eg, parenchymal proliferation, inflammation, angiogenesis, and matrix remodeling. OBJECTIVES: The aim of this study was to investigate the hypothesis that tSVF reduces postsurgical scar formation. METHODS: This prospective, double-blind, placebo-controlled, randomized trial was conducted between 2016 and 2020. Forty mammoplasty patients were enrolled and followed for 1 year. At the end of the mammoplasty procedure, all patients received tSVF in the lateral 5 cm of the horizontal scar of 1 breast and a placebo injection in the contralateral breast to serve as an intrapatient control. Primary outcome was scar quality measure by the Patient and Observer Scar Assessment Scale (POSAS). Secondary outcomes were obtained from photographic evaluation and histologic analysis of scar tissue samples. RESULTS: Thirty-four of 40 patients completed follow-up. At 6 months postoperation, injection of tSVF had significantly improved postoperative scar appearance as assessed by the POSAS questionnaire. No difference was observed at 12 months postoperation. No improvement was seen based on the evaluation of photographs and histologic analysis of postoperative scars between both groups. CONCLUSIONS: Injection of tSVF resulted in improved wound healing and reduced scar formation at 6 months postoperation, without any noticeable advantageous effects seen at 12 months.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. van Dongen JA, van Boxtel J, Uguten M, et al. Tissue Stromal Vascular Fraction Improves Early Scar Healing: A Prospective Randomized Multicenter Clinical Trial. Aesthet Surg J. 2022. PMID: 34967864. doi:10.1093/asj/sjab431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。